431,00 € excl.VAT – 450,00 € excl.VAT
This antibody reacts with the CD45RO antigen, which is present at low density early in the T-lymphocyte maturation cycle. Upon activation by phytohemagglutinin (PHA) or alloantigen, naive T lymphocytes first acquire CD45RO and then lose CD45RA. When these activated T lymphocytes are rechallenged, the cells that exhibit a secondary response are primarily CD45RO +, leading to the concept that CD45RO + cells are a primed population of memory T lymphocytes.
In peripheral blood, the CD45RO antigen is present on approximately 40% of resting peripheral blood T lymphocytes, including the CD4 + and CD8 + subpopulations, as well as on most thymocytes and activated T lymphocytes. It is also expressed on monocytes, macrophages, and granulocytes.
| Conjugated | |
|---|---|
| Size | |
| Regulatory Status | |
| Clone | |
| Gene ID | |
| Format | |
| Species Reactivity | |
| Isotype | |
| Tested Applications | |
| Clonality | |
| UniProt | |
| Mw | |
| Population | B- Cell, Dendrititic Cell, Granulocyte, Macrophage/Monocyte, NK Cell, Stem Cell/Precursor, T-Cell |
| Volumen/test | |
| Almacenamiento | Store in the dark at 2-8°C. |
| Otros nombres | Restricted T200. |
| Buffer | The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3). |
| Immunogen | Human IL-2-dependent T-cell line. |
| Concentración | 0,05 mg/ml, 0,2 mg/ml |
CD45RO, clone UCHL1 is a mAb intended for identification/enumeration of CD45RO present on approx. 40% of peripheral blood T lymph using FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.
| Product description | Reference | Title | Authors | Journal | Year | |
|---|---|---|---|---|---|---|
| Product description | Reference | Title | Authors | Journal | Year |